Resultats de la cerca - Eyassu Chernet

  • Mostrar 1 - 5 resultats de 5
Refinar resultats
  1. 1
    Synthesis, Ex Vivo Evaluation, and Radiolabeling of Potent 1,5-Diphenylpyrrolidin-2-one Cannabinoid Subtype-1 Receptor Ligands as Candidates for In Vivo Imaging

    Synthesis, Ex Vivo Evaluation, and Radiolabeling of Potent 1,5-Diphenylpyrrolidin-2-one Cannabinoid Subtype-1 Receptor Ligands as Candidates for In Vivo Imaging per Sean Donohue, Joseph H. Krushinski, Victor W. Pike, Eyassu Chernet, Lee A. Phebus, Amy K. Chesterfield, Christian C. Felder, Christer Halldin, John M. Schaus

    Publicat 2008
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease

    Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease per Yansheng Du, Zhizhong Ma, Suizhen Lin, Richard Dodel, Feng Gao, Kelly R. Bales, Lazarose C. Triarhou, Eyassu Chernet, Ken Perry, David L. Nelson, Susan Luecke, Lee A. Phebus, Frank P. Bymaster, Steven M. Paul

    Publicat 2001
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    The PET Radioligand [11C]MePPEP Binds Reversibly and with High Specific Signal to Cannabinoid CB1 Receptors in Nonhuman Primate Brain

    The PET Radioligand [11C]MePPEP Binds Reversibly and with High Specific Signal to Cannabinoid CB1 Receptors in Nonhuman Primate Brain per Fumihiko Yasuno, Amira K. Brown, Sami S. Zoghbi, Joseph H. Krushinski, Eyassu Chernet, J. Tauscher, John M. Schaus, Lee A. Phebus, Amy K. Chesterfield, Christian C. Felder, Robert L. Gladding, Jinsoo Hong, Christer Halldin, Victor W. Pike, Robert B. Innis

    Publicat 2007
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    Biased M1-muscarinic-receptor-mutant mice inform the design of next-generation drugs

    Biased M1-muscarinic-receptor-mutant mice inform the design of next-generation drugs per Sophie J. Bradley, Colin Molloy, Paulina Valuskova, Louis Dwomoh, Miriam Scarpa, Mario Rossi, L. H. Finlayson, Kjell Svensson, Eyassu Chernet, Vanessa N. Barth, Karolina Gherbi, David A. Sykes, Caroline A. Wilson, Rajendra Mistry, Patrick M. Sexton, Arthur Christopoulos, Adrian J. Mogg, Elizabeth M. Rosethorne, Shuzo Sakata, R. A. John Challiss, Lisa M. Broad, Andrew B. Tobin

    Publicat 2020
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Preclinical profile of a dopamine D1 potentiator suggests therapeutic utility in neurological and psychiatric disorders

    Preclinical profile of a dopamine D1 potentiator suggests therapeutic utility in neurological and psychiatric disorders per Robert F. Bruns, Stephen N. Mitchell, Keith A. Wafford, Alex Harper, Elaine Shanks, Guy Carter, Michael J. O’Neill, Tracey K. Murray, Brian J. Eastwood, John M. Schaus, James P. Beck, Junliang Hao, Jeffrey M. Witkin, Xia Li, Eyassu Chernet, Jason Katner, Hong Wang, John Ryder, Meghane E. Masquelin, Linda Thompson, Patrick L. Love, Deanna L. Maren, Julie F. Falcone, Michelle M. Menezes, Linli Zhang, Charles R. Yang, Kjell Svensson

    Publicat 2017
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: